Calcium gluconate iv how fast

Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. Updated visitor guidelines. Top of the page. What is the most important information I should know about calcium gluconate?

What is calcium gluconate? Calcium gluconate is used to prevent or to treat calcium deficiencies. Calcium gluconate may also be used for purposes not listed in this medication guide. What should I discuss with my healthcare provider before using calcium gluconate? Tell your doctor if you have ever had: heart problems; kidney disease; kidney stones; cancer; a parathyroid gland disorder; or high levels of calcium in your blood.

How should I use calcium gluconate? Use exactly as directed on the label, or as prescribed by your doctor. Take calcium gluconate oral with plenty of water.

What happens if I miss a dose? What happens if I overdose? Seek emergency medical attention or call the Poison Help line at What should I avoid while using calcium gluconate? What are the possible side effects of calcium gluconate? What other drugs will affect calcium gluconate? Many drugs can affect calcium gluconate, especially: baloxavir marboxil Xofluza ; digoxin digitalis ; an antibiotic; or other forms of calcium. Where can I get more information? For the treatment of symptomatic hypocalcaemia and hyperkalaemia in the neonate.

This document is only valid for the day on which it is accessed. Please read our disclaimer. Newborn intensive care. This means that a record must be kept of babies to whom it has been administered, and parents should be informed that it is not registered for use in NZ. Contraindications Hypercalcaemia Severe hypercalcuria Severe renal or cardiac disease Ventricular fibrillation.

Precautions Renal impairment Dehydration or electrolyte imbalance. Repeated or prolonged use - increases risk of aluminum toxicity. Diseases associated with elevated vitamin D concentrations. Possible adverse effects Extravasation of intravenous injection can cause tissue necrosis or calcium deposition. Special considerations Avoid intra-arterial and subcutaneous administration.

Adjust dose in renal failure. Ceftriaxone - may cause insoluble precipitates and can be fatal Thiazide diuretics - increases risk of hypercalcaemia Monitoring: ECG is recommended to monitor for evidence of hypercalcaemia, bradycardia and other arrhythmias.

Treatment of asymptomatic neonatal hypocalcaemia is controversial. IV preparation Clear colourless solution pH Compatible solutions: sodium chloride 0.

Nursing considerations Give via central line unless otherwise instructed by neonatologist - do not use scalp veins. Observe IV insertion site closely for extravasation Observe IV tubing for precipitates Monitor for adverse reactions Continuous cardiac monitoring during administration of slow IV infusion via a syringe pump.

Nursing 97 Drug Handbook Springhouse , p Calcium gluconate - Micromedex. Gloucester, UK: hameln pharmaceuticals ltd, Do NOT administer intramuscularly or subcutaneously. Visually inspect parenteral products for particulate matter and discoloration prior to administration whenever solution and container permit. Observe the infusion line closely.

Higher concentrations have been given via central lines. Do not administer via scalp vein catheter. Generally, infuse a bolus dose over 30 to 60 minutes. Administer through a small needle into a large vein. During cardiopulmonary resuscitation in pediatrics, calcium gluconate may be given via the intraosseous route when IV access is not available. Generic: - Discard unused portion.

Do not store for later use. Calcium gluconate is contraindicated in patients with ventricular fibrillation and should be used cautiously in patients with preexisting cardiac arrhythmias. Calcium gluconate is not recommended for routine use during cardiopulmonary resuscitation, except when indications exist to counterbalance electrolyte disturbances.

Calcium gluconate should not be used in patients with digitalis toxicity because of an increased risk of developing arrhythmias. Cardiac glycosides and calcium gluconate both increase intracellular calcium, so calcium gluconate can worsen digitalis toxicity. Cardiac glycoside therapy, however, does not preclude the use of calcium gluconate. Cardiac monitoring is recommended during IV infusion to avoid serious cardiac adverse events.

Calcium gluconate should not be given by intramuscular administration or subcutaneous administration. Severe necrosis and sloughing may occur. Caution should also be taken to avoid extravasation or accidental injection into perivascular tissues.

Calcium gluconate should be used with caution in patients with chronic renal failure due to the increased risk of developing hypercalcemia. Additionally, calcium gluconate formulations contain aluminum content varies with formulation. Thus, aluminum may reach toxic concentrations with prolonged administration in patients with renal impairment. Premature neonates are at particular risk for aluminum toxicity because of immature renal function and they require large amounts of calcium and phosphate solutions, which contain aluminum.

Tissue loading may occur at lower administration rates. Calcium gluconate should be used cautiously, if at all, in patients with vitamin D toxicity or hyperparathyroidism. Hypercalcemia is likely to occur in either of these conditions. Calcium gluconate should be used with caution in patients with preexisting hypercalciuria or nephrolithiasis, especially if renal calculi are present.

Calcium gluconate should be used with caution in patients with sarcoidosis as hypercalcemia is more likely to occur in these patients.

Animal reproduction studies have not been conducted with calcium gluconate. It is unknown if calcium gluconate can cause fetal harm when administered during pregnancy or can affect reproductive capacity.

Calcium gluconate should be given to a pregnant woman only if clearly needed. There are no data available on the presence of calcium gluconate in human milk, the effect on the breastfed infant, or the effect on milk production. Consider the benefits of breast-feeding, the risk of infant drug exposure, and the risk of an untreated or inadequately treated condition.

Calcium is the primary component of skeletal tissue, providing structural integrity and support for individual growth.